WITHDRAWAL SYMPTOMS FOLLOWING DISCONTINUATION OF IMIPRAMINE THERAPY
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clonazepam has a long elimination half-life and induced less frequently rebound anxiety than alprazolam.
“Clonazepam [73-76] has a long elimination half-life, induced less frequently rebound anxiety than alprazolam [77].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [77]
Cites
Schweizerische medizinische Wochenschrift
(1947) · JAMA · doi:10.1001/jama.1947.02880050057017 · Cited by 958 · see citing works
Withdrawal reactions from chlordiazepoxide (?Librium?)
Hollister, L. E., Motzenbecker, F. P., & Degan, R. O. (1961) · Psychopharmacologia · doi:10.1007/bf00429621 · Cited by 340 · see citing works
Clinical Experience with Imipramine (G 22355) in the Treatment of Depression
Mann, A. M., & Macpherson, A. S. (1959) · Canadian Psychiatric Association Journal · doi:10.1177/070674375900400111 · Cited by 57 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Hollister L. E., 1960, J. Clin. Exp. Psychopath., 21, 212
- Turner W. J., J. Neuropsychiat., 2, 1961
Cited by
Sorted by citations
Amphetamine abuse. Pattern and effects of high doses taken intravenously
Kramer, J. C. (1967) · JAMA · doi:10.1001/jama.201.5.305 · Cited by 313 · see citing works
Self-citationAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Clinical use of quetiapine in disease states other than schizophrenia.
Dl, D., Laird, L. K., Zajecka, J., Bailey, L., Sussman, N., & Seabolt, J. L. (2002) · PubMed · Cited by 229 · see citing works
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223 · see citing works
Antidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214 · see citing works
Montgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196 · see citing works
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158 · see citing works
Effects of maintenance amitriptyline and psychotherapy on symptoms of depression
Paykel, E. S., DiMascio, A., HASKELL, D. S., & Prusoff, B. A. (1975) · Psychological Medicine · doi:10.1017/s0033291700007236 · Cited by 144 · see citing works
Antidepressant discontinuation: a review of the literature.
Lejoyeux, M., & Adès, J. (1997) · PubMed · Cited by 135 · see citing works
Abrupt Discontinuation of Tricyclic Antidepressant Drugs: Evidence for Noradrenergic Hyperactivity
Charney, D. S., Heninger, G. R., Sternberg, D. E., & Landis, D. H. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.141.4.377 · Cited by 126 · see citing works
The SSRI discontinuation syndrome
Haddad, P. M. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 123 · see citing works
Antidepressant Withdrawal and Rebound Phenomena
Henssler, J. F., Heinz, A., Brandt, L., & Bschor, T. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0355 · Cited by 116 · see citing works
Recognising and managing antidepressant discontinuation symptoms
Haddad, P. M., & Anderson, I. M. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.105.001966 · Cited by 109 · see citing works
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00133-0 · Cited by 106 · see citing works
Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03686.x · Cited by 103 · see citing works
Compliance with antidepressant therapy and antidepressant discontinuation symptoms
Demyttenaere, K., & Haddad, P. M. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10948.x · Cited by 98 · see citing works
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95 · see citing works
Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
Nutt, D. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174019 · Cited by 84 · see citing works
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84 · see citing works
Bogetto, F., Bellino, S., Revello, R. B., & Patria, L. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00006 · Cited by 80 · see citing works
Antidepressant Withdrawal Syndrome
Lejoyeux, M., Adès, J., Mourad, I., Solomon, J., & Dilsaver, S. C. (1996) · CNS Drugs · doi:10.2165/00023210-199605040-00006 · Cited by 82 · see citing works
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava, G. A., & Cosci, F. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19com12794 · Cited by 69 · see citing works
Antidepressant withdrawal symptoms treated with anticholinergic agents
Dilsaver, S. C., Feinberg, M. P., & Greden, J. F. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.2.249 · Cited by 67 · see citing works
Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications
Looper, K. J. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.1.1 · Cited by 66 · see citing works
Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 66 · see citing works
Gastaldon, C., Schoretsanitis, G., Arzenton, E., Raschi, E., Papola, D., Ostuzzi, G., Moretti, U., Seifritz, E., Kane, J. M., Trifirò, G., et al. (2022) · Drug Safety · doi:10.1007/s40264-022-01246-4 · Cited by 66 · see citing works
Withdrawal phenomena associated with antidepressant and antipsychotic agents
Dilsaver, S. C. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00002 · Cited by 60 · see citing works
Are benzodiazepines overused and abused?
Rickels, K. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01842.x · Cited by 61 · see citing works
Kruger, J., Conway, T., Kaneene, J., Perry, R. L., Hagenlocker, E., Golombek, A., & Stuhler, J. (2003) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2003.222.749 · Cited by 64 · see citing works
Why do we need new and better antidepressants?
Montgomery, S. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000199455.39552.1c · Cited by 59 · see citing works
LADER, M. H. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.004 · Cited by 59 · see citing works
A review of antidepressant treatments today
Kennedy, S. H. (2006) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(06)70007-4 · Cited by 55 · see citing works
Withdrawal effects of phenothiazines
Simpson, G. M., Amin, M., & Kunz, E. (1965) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(65)80028-1 · Cited by 50 · see citing works
Rheker, J., Winkler, A., Doering, B. K., & Rief, W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4466-8 · Cited by 52 · see citing works
Tricyclic Antidepressant Withdrawal Syndrome
Garner, E. M., Kelly, M. W., & Thompson, D. F. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700912 · Cited by 49 · see citing works
Groot, P. C., & van Os, J. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320932452 · Cited by 49 · see citing works
Narayan, V., & Haddad, P. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359094 · Cited by 48 · see citing works
The Damnation of Benzodiazepines
Taylor, F. K. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.697 · Cited by 45 · see citing works
Withdrawal symptoms after graduated cessation of imipramine in children
Law, W., Petti, T. A., & Kazdin, A. E. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.5.647 · Cited by 41 · see citing works
Drug withdrawal syndromes-- a literature review.
Hodding, G., Jann, M. W., & Ackerman, I. P. (1980) · PubMed Central · Cited by 39 · see citing works
O’Keane, V., O’Flynn, K., Lucey, J. V., & Dinan, T. G. (1992) · Psychological Medicine · doi:10.1017/s0033291700032724 · Cited by 38 · see citing works
Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
Dilsaver, S. C. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90097-z · Cited by 36 · see citing works
Compliance and acceptance in antidepressant treatment
Demyttenaere, K. (2001) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500152048423 · Cited by 35 · see citing works
Overdose of Tricyclic Anti-Depressants and Deductions Concerning their Cerebral Action
LEWIS, S. A., & Oswald, I. (1969) · The British Journal of Psychiatry · doi:10.1192/bjp.115.529.1403 · Cited by 35 · see citing works
Antidepressant withdrawal syndromes: phenomenology and pathophysiology
Dilsaver, S. C. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb08578.x · Cited by 33 · see citing works
Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
Duncan, J. S., Shorvon, S. D., & Trimble, M. R. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.7.924 · Cited by 33 · see citing works
Remembering the lost neuroscience of pharmaco‐EEG
Fink, M. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01467.x · Cited by 32 · see citing works
Self-citationAnticholinergic Drug Abuse and Misuse
Marken, P. A., Stoner, S. C., & Bunker, M. T. (1996) · CNS Drugs · doi:10.2165/00023210-199605030-00005 · Cited by 31 · see citing works
Delirium after abrupt withdrawal from doxepin: case report
Santos, A. B., & MCCURDY, L. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.239 · Cited by 28 · see citing works
SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
Hosenbocus, S., & Chahal, R. (2011) · PubMed Central · Cited by 27 · see citing works
Withdrawal Symptoms After Abrupt Cessation of Amitriptyline in an Eight-Year-Old Boy
Gualtieri, C. T., & Staye, J. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.1979.136.4a.457 · Cited by 27 · see citing works
Withdrawal Symptoms after Abrupt Termination of Imipramine
Shatan, C. F. (1966) · Canadian Psychiatric Association Journal · doi:10.1177/070674376601101s27 · Cited by 27 · see citing works
Abrupt Cessation of High-Dose Imipramine Treatment in Children
Petti, T. A. (1981) · JAMA · doi:10.1001/jama.1981.03320070052026 · Cited by 24 · see citing works
Potential Sensitising Effects of Antidepressant Drugs on Depression
Fava, G. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00001 · Cited by 23 · see citing works
Clinical Consequences of Abrupt Drug Withdrawal
George, C. F., & Robertson, D. (1987) · Medical Toxicology · doi:10.1007/bf03259954 · Cited by 23 · see citing works
Antidepressants: A Clinical Update for Medical Practitioners
Richardson, J. W., & Richelson, E. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61429-3 · Cited by 22 · see citing works
Amantadine-associated recurrence of psychosis
Hausner, R. S. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.240 · Cited by 22 · see citing works
Drug dependence as a criterion for differentiation of psychotropic drugs
Battegay, R. (1966) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(66)80030-5 · Cited by 20 · see citing works
Pharmacological stress diathesis syndromes
Healy, D., & Tranter, R. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300312 · Cited by 19 · see citing works
Jesberger, J. A., & Richardson, J. S. (1986) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(86)90044-3 · Cited by 15 · see citing works
Lithium discontinuation: Withdrawal or relapse?
Balon, R., Yeragani, V. K., Pohl, R. B., & Gershon, S. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90056-9 · Cited by 14 · see citing works
A study of abrupt lithium withdrawal
Rifkin, A. E., Quitkin, F. M., Howard, A., & Klein, D. F. (1975) · Psychopharmacology · doi:10.1007/bf00421003 · Cited by 14 · see citing works
Self-citationRecognition and management of antidepressant discontinuation syndrome
Bhat, V., & Kennedy, S. H. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170022 · Cited by 13 · see citing works
Clinical Applications of Antidepressant Drugs in Childhood Behavioral and Emotional Disorders
Rancurello, M. (1985) · Psychiatric Annals · doi:10.3928/0048-5713-19850201-07 · Cited by 13 · see citing works
Transient Mood Elevation Associated with Antidepressant Drug Decrease*
Corral, M., Sivertz, K., & Jones, B. D. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200906 · Cited by 11 · see citing works
Considerations in Drug Therapy of the Elderly
Lamy, P. P. (1979) · Journal of Drug Issues · doi:10.1177/002204267900900103 · Cited by 10 · see citing works
Are all antidepressants the same? The consumer has a point
Camino, S., Strejilevich, S. A., Godoy, A., Smith, J., & Szmulewicz, A. (2022) · Psychological Medicine · doi:10.1017/s0033291722000678 · Cited by 9 · see citing works
Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review
Moncrieff, J., Hobday, H., Sørensen, A., Read, J., Plöderl, M., Hengartner, M. P., Kamp, C. B., Jakobsen, J. C., Juul, S., Davies, J., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725100652 · Cited by 9 · see citing works
Protracted Vomiting following Abrupt Cessation of Psychotropics: A Case Report
Kalman, T. P., & Warner, G. M. (1978) · Canadian Psychiatric Association Journal · doi:10.1177/070674377802300307 · Cited by 9 · see citing works
Godt, H. H., Fredslund-Andersen, K., & Edlund, A. H. (1971) · Nordic Journal of Psychiatry · doi:10.3109/08039487109094663 · Cited by 8 · see citing works
Rennwald, A., & Hengartner, M. P. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602500023x · Cited by 8 · see citing works
“Acute withdrawal syndromes have been reported over decades in various case reports (e.g. Bloch et al. , 1995; Kostic et al. , 2024; Kramer et al. , 1961) and were later confirmed in placebo-controlled treatment-interruption trials (e.g. Michelson et al. , 2000; Rosenbaum et al. , 1998), and…”
Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium
Lawrence, J. M. (1985) · Psychosomatics · doi:10.1016/s0033-3182(85)72778-8 · Cited by 7 · see citing works
Behavioral Toxicity of Psychiatric Drugs
Perl, M., Hall, R. C. W., & Gardner, E. R. (1980) · Psychiatric Presentations of Medical Illness · doi:10.1007/978-94-011-7677-4_18 · Cited by 6 · see citing works
Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2013) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-130594 · Cited by 6 · see citing works
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 7 · see citing works
Glanger, M. R., Peterson, G. M., & Abraham, A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15320 · Cited by 5 · see citing works
Lee, E. A., Wong, C.-A., Barrio, L., Godoy, E. R., Hackett, D. L., Thompson, N., Dreskin, M., Kumar, S., Khang, P. S., Steinberg, S. G., et al. (2023) · The Permanente Journal · doi:10.7812/tpp/22.052 · Cited by 5 · see citing works
Chronic Amitriptyline Toxicity
Giller, E. L., Bialos, D., Docherty, J. P., Jatlow, P. I., & Harkness, L. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.1979.136.4a.458 · Cited by 5 · see citing works
Random Controlled Trial of Sham Electroconvulsive Therapy and Other Novel Therapies
Fink, M. (2021) · Journal of Ect · doi:10.1097/yct.0000000000000759 · Cited by 5 · see citing works
Self-citationTreatment-induced stress syndromes
Healy, D. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.01.038 · Cited by 5 · see citing works
Kielholz, P., Battegay, R., & Ladewig, D. (1972) · Springer eBooks · doi:10.1007/978-3-642-65280-6_11 · Cited by 5 · see citing works
Effects of Discontinuation of Antipanic Medication
Fyer, A. J. (1988) · Springer eBooks · doi:10.1007/978-3-642-73543-1_4 · Cited by 5 · see citing works
The use of antidepressant drugs: some reasons for concern
Fava, G. A., & Tomba, E. (1998) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-1998-155 · Cited by 5 · see citing works
(2005) · CRC Press eBooks · doi:10.1201/b14455-5 · Cited by 5 · see citing works
Panic Anxiety after Abrupt Discontinuation of Mianserin
Kuniyoshi, M., Arikawa, K., Miura, C., & Inanaga, K. (1989) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1989.tb02564.x · Cited by 4 · see citing works
Psychiatric Reaction Patterns to Imipramine
Klein, D. F., & Fink, M. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.4.foc549 · Cited by 4 · see citing works
Self-citationDo withdrawal symptoms predict depression relapse after antidepressant cessation?
Volkmann, C., Abulikemu, S., Berwian, I. M., Huys, Q. J. M., & Walter, H. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02005-z · Cited by 4 · see citing works
La dépendance aux médicaments psychotropes. De la psychopharmacologie aux usages
Moigne, P. L. (2009) · Drogues santé et société · doi:10.7202/019619ar · Cited by 3 · see citing works
Cardiac arrhythmia following rapid imipramine withdrawal
Regan, W. M., Margolin, R. A., & Mathew, R. J. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90201-1 · Cited by 3 · see citing works
Lack of withdrawal symptoms after discontinuation of mianserin
Otani, K., Sasa, H., Kaneko, S., & Fukushima, Y. (1991) · The Lancet · doi:10.1016/0140-6736(91)92487-m · Cited by 3 · see citing works
PHYSICAL TREATMENTS FOR DEPRESSION
Merson, S., & Tyrer, P. J. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-356510-5.50008-x · Cited by 3 · see citing works
PSYCHOPHARMACOLOGY AND PHYSIOLOGICAL TREATMENT
WORTIS, J. (1963) · American Journal of Psychiatry · doi:10.1176/ajp.119.7.621 · Cited by 3 · see citing works
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Volkmann, C., Abulikemu, S., Berwian, I. M., Huys, Q. J., & Walter, H. (2023) · doi:10.31234/osf.io/fxye5 · Cited by 2 · see citing works
Evaluating Antidepressants and Anxiolytics
Rickels, K. (1990) · Springer eBooks · doi:10.1007/978-3-642-75370-1_1 · Cited by 2 · see citing works
Flu-like illness after discontinuance of imipramine
Shrivastava, R. K., & Itil, T. M. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90159-3 · Cited by 2 · see citing works
Psychosomatic medicine:alive and well in the new century
Fava, G. A., Fabbri, S., Belaise, C., & Tossani, E. (2002) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1 · see citing works
Chemotherapy of Affective Disorders
Sullivan, J. L., Taska, R. J., Wise, T. N., & GOLDSTEIN, D. M. (1984) · Elsevier eBooks · doi:10.1016/b978-0-409-95151-6.50009-2 · Cited by 1 · see citing works
Le syndrome de sevrage des antidépresseurs
Lejoyeux, M., & Adès, J. (1989) · Psychiatry and Psychobiology · doi:10.1017/s0767399x00001395 · Cited by 1 · see citing works
Comment on Lorazepam Withdrawal
Einarson, T. R. (1981) · Annals of Pharmacotherapy · doi:10.1177/106002808101500218 · Cited by 1 · see citing works
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1 · see citing works
- Authors
- KRAMER, J. C., KLEIN, D. F., & FINK, M.
- ORCID
- KRAMER, JOHN C.
- Venue
- American Journal of Psychiatry
- Published
- 1961-12
- Volume
- 118
- Issue
- 6
- Pages
- 549-550
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2017775384
- Semantic Scholar
- 67ab2b254e05d6f71317a5f6063102943268efa6
- Cited by
- 113
- References
- 3
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 2 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- imipramine, drug withdrawal symptoms, antidepressant discontinuation, tricyclic antidepressants, adverse drug reactions
- MeSH terms
- Imipramine, Psychopharmacology, Substance Withdrawal Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
